α-Adrenergic supersensitivity and decreased number of α-adrenoceptors in heart from acute diabetic rats

The inotropic effect of methoxamine, as well as the α-adrenoceptor population, were measured in cardiac tissue from normal and short-term (3 days) diabetic rats. Methoxamine increased the tension of both normal and diabetic ventricles, but in diabetic ones, the dose-response curve to methoxamine was...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Wald, M.
Otros Autores: Borda, E.S, Sterin-Borda, L.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1988
Materias:
Acceso en línea:Registro en Scopus
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 04637caa a22006857a 4500
001 PAPER-18052
003 AR-BaUEN
005 20230518204925.0
008 190411s1988 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0023689819 
024 7 |2 cas  |a 1 (5 isoquinolinesulfonyl) 2 methylpiperazine, 84477-87-2; methoxamine, 390-28-3, 61-16-5; n (2 aminoethyl) 5 isoquinolinesulfonamide, 84468-17-7; phentolamine, 50-60-2, 73-05-2; prazosin, 19216-56-9, 19237-84-4; propranolol, 13013-17-7, 318-98-9, 3506-09-0, 4199-09-1, 525-66-6; Methoxamine, 390-28-3; Prazosin, 19216-56-9; Receptors, Adrenergic, alpha 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a CJPPA 
100 1 |a Wald, M. 
245 1 0 |a α-Adrenergic supersensitivity and decreased number of α-adrenoceptors in heart from acute diabetic rats 
260 |c 1988 
506 |2 openaire  |e Política editorial 
520 3 |a The inotropic effect of methoxamine, as well as the α-adrenoceptor population, were measured in cardiac tissue from normal and short-term (3 days) diabetic rats. Methoxamine increased the tension of both normal and diabetic ventricles, but in diabetic ones, the dose-response curve to methoxamine was shifted to the left and the efficacy of the α-agonist was enhanced. This phenomenon was accompanied by an increase in receptor affinity, while the number of α-adrenoceptor sites decreased. Inhibitors of α1-adrenoceptors blocked, in a competitive manner, the positive inotropic effect of methoxamine in both types of ventricles. Inhibition of phospholipase C blocked the ventricular response to the methoxamine in nondiabetic as well as in diabetic hearts. Synthetic diacylglyceride (DAG) potentiated the inotropic action of the α-agonist in normal ventricles and increased the affinity with a decreased number of α-adrenoceptor sites in normal ventricles, producing values of K(d) of B(max) similar to those of the acute diabetic heart. Inhibitors of protein kinase C partially reduced the supersensitivity to α-agonists in diabetic ventricles and prevented the stimulatory action of DAG upon the positive inotropic effect of methoxamine in normal ventricles. These results suggest that α-adrenergic inotropic stimulation is secondary to receptor-mediated hydrolysis of phosphoinositides, generating some oxidative metabolites (DAG) which, in turn, may be responsible for the inotropic effect. In the acute diabetic state, the supersensitivity to α-agonist could be due to high activity of phospholipase C (with an increase in DAG production) which induces alteration in the membrane α-adrenergic receptors.  |l eng 
593 |a Centrol de Estudios Farmacologicos y de Principios Naturales (CEFAPRIN), Consejo Nacional de Investigaciones Cientificas, (1414) Buenos Aires, Argentina 
690 1 0 |a 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE 
690 1 0 |a ALPHA ADRENERGIC RECEPTOR 
690 1 0 |a DIACYLGLYCEROL 
690 1 0 |a METHOXAMINE 
690 1 0 |a N (2 AMINOETHYL) 5 ISOQUINOLINESULFONAMIDE 
690 1 0 |a PHENTOLAMINE 
690 1 0 |a PRAZOSIN 
690 1 0 |a PROPRANOLOL 
690 1 0 |a ANIMAL CELL 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a DIABETES MELLITUS 
690 1 0 |a HEART VENTRICLE 
690 1 0 |a INOTROPISM 
690 1 0 |a MALE 
690 1 0 |a NONHUMAN 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a RAT 
690 1 0 |a ANIMAL 
690 1 0 |a DIABETES MELLITUS, EXPERIMENTAL 
690 1 0 |a DOSE-RESPONSE RELATIONSHIP, DRUG 
690 1 0 |a KINETICS 
690 1 0 |a MALE 
690 1 0 |a METHOXAMINE 
690 1 0 |a MYOCARDIAL CONTRACTION 
690 1 0 |a MYOCARDIUM 
690 1 0 |a PRAZOSIN 
690 1 0 |a RATS 
690 1 0 |a RATS, INBRED STRAINS 
690 1 0 |a RECEPTORS, ADRENERGIC, ALPHA 
690 1 0 |a SUPPORT, NON-U.S. GOV'T 
653 0 0 |a h 9, sigma; h7, sigma 
700 1 |a Borda, E.S. 
700 1 |a Sterin-Borda, L. 
773 0 |d 1988  |g v. 66  |h pp. 1154-1160  |k n. 9  |p CAN. J. PHYSIOL. PHARMACOL.  |x 00084212  |w (AR-BaUEN)CENRE-2805  |t Canadian Journal of Physiology and Pharmacology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023689819&partnerID=40&md5=980a2ce033a34b48e5784d6cba828980  |y Registro en Scopus 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00084212_v66_n9_p1154_Wald  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00084212_v66_n9_p1154_Wald  |y Registro en la Biblioteca Digital 
961 |a paper_00084212_v66_n9_p1154_Wald  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 79005